Clinical Trial Update: Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial updating nanoliposomal irinotecan for head and neck cancer after platinum-based therapy or chemoradiotherapy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Nanoliposomal irinotecan (irinotecan liposomal)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Head & Neck Cancer | Phase 2 | Status: COMPLETED